🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What a thrill it was for us to celebrate your Nobel Prize with you, Carolyn Bertozzi!! We're so honored to have the opportunity to work with you, learn from you, and build on your incredible work! Excited for all the possibilities ahead for #LYTAC medicines!

Today, we celebrate International Day of Women and Girls in Science. Lycia is a woman-founded and woman-led company. We thrive here in our culture of diversity, equity and inclusion. Learn more about the day: bit.ly/40R82yM #EquityInScience #WomeninScience

On #IWD2023, we recognize the amazing women of Lycia, and we join with women & their allies across the world to celebrate this year's theme: #EmbraceEquity Today and every day, we're proud to be proactively building a workplace that is #diverse, #equitable & #inclusive.

Our President & CEO Aetna will present at the Jefferies Healthcare Conference on Wed., June 7, describing out LYTAC platform to discover & develop first-in-class therapeutics that degrade extracellular & membrane bound proteins. bit.ly/3CdtD9O #JefferiesHealthcare

We're thrilled to announce the completion of a $106.6 million Series C financing to progress our lead LYTAC extracellular protein degraders into the clinic for unmet needs in #autoimmune and #inflammatory diseases. Read release: bit.ly/44EG63u

Thanks, MedCity News Frank Vinluan for covering our Series C financing and our continued progress advancing our lead LYTAC extracellular protein degrader programs toward the clinic for #autoimmune and #inflammatory diseases. Read article: bit.ly/4bCgWVk

We're excited to welcome Andrew Gottesdiener, M.D., Partner Venrock to our Board of Directors, concurrent with our $106.6M Series C financing, announced yesterday. Read the press release: bit.ly/44EG63u

A big thanks to NYSE 🏛 for celebrating our Series C financing on the trading floor last week! We're excited to continue advancing our lead LYTAC degraders toward the clinic for #autoimmune and #inflammatory diseases!

Our CEO, Aetna Wun Trombley, will participate in a panel on Wed., June 5 at #BIO2024, moderated by Mariana Mihalusova Venrock, discussing novel approaches to co-opting biological processes - incl. our LYTAC extracellular protein degraders - to drug a spectrum of diseases. #BIO24

Our CataLYTAC research is live on bioRxiv. CataLYTACs offer faster, deeper, and longer-lasting degradation of soluble targets, showing the power of catalytic protein degradation. Read more about this progress in extracellular therapies here: bit.ly/4fVB0UF

Last week, we partnered with Biocom’s Generation #STEAM to inspire the next generation! We hosted Tennyson HS students for lab tours, career panels, and hands-on activities. Our team also assembled 209 STEAM kits for Martin Elementary and BioLink Depot. Proud to give back!

Please join us in welcoming Chin Lee, MD, MPH, as Lycia’s Chief Medical Officer to help advance our pipeline of LYTAC-based therapies for autoimmune diseases. Welcome, Dr. Lee! globenewswire.com/news-release/2…

Lycia’s leadership will attend the 2025 AAAAI/WAO Joint Congress in San Diego, Feb 28 – Mar 3. We’re excited to discuss the latest in allergy & immunology R&D and share how our LYTAC platform is shaping the future of targeted protein degradation. Let's connect at #AAAAI2025!

Science fuels progress, drives innovation, and improves lives. We’re proud to stand up for research and evidence-based decision-making at the #StandUpForScience2025 Rally —where our founder, Nobel Laureate Carolyn Bertozzi will be a featured speaker. Join us!

We stood up for science! On Friday, our team joined the #StandUpForScience2025 Rally to support research & innovation. Amazing energy, inspiring voices—let’s keep advocating for science! #ScienceMatters #ResearchForAll #StandUpForScience

At Lycia, we’re pioneering a new approach to treating previously undruggable diseases. If you’re passionate about pushing the boundaries of science, we’re hiring! Check out our job openings: jobs.lever.co/LyciaTherapeut… #LifeAtLycia #BiotechCareers

This #PatientExperienceWeek, we celebrate more than care; we celebrate collaboration. Patient insights and lived experiences are essential to shaping clinical trials that are truly inclusive, accessible, and meaningful. When we listen, we learn and do better for everyone.

It's National #Asthma & #Allergy Awareness Month, a time to support those living with allergic conditions. At Lycia, we’re working to advance new treatments for asthma, food allergies, and chronic urticaria. Together, let’s drive progress.

It’s #FoodAllergy Awareness Week. Over 33M Americans face life-threatening food allergies. Limited treatments leave many at risk. Join us in the fight for better solutions through research, education, and advocacy: bit.ly/4l2tdIh

Graves’ disease affects millions, and no two journeys are the same. This International Thyroid Awareness Week, we support those seeking answers and better care. Your thyroid health matters. #Thyroid #GravesDisease